Recent Articles
Can VEGFR Antibodies Become a Ne...
Th1/Th2 Subset Differentiation: ...
Paired Antibodies for Progestero...
Vimentin Biomarker Research: Antibody Tools to Characterize VIMhigh Immunosup...
Molecular Architecture and Core Cellular Functions of Vimentin Intermediate Filament Protein Vimentin belongs to type III intermediate filament (IF) proteins selectively enriched within mesenchymal-derived cell populations across mammalian tissue systems....
Vimentin Biomarker Research: Antibody Tools to Characterize VIMhigh Immunosup...
Molecular Architecture and Core Cellular Functions of Vimentin Intermediate Filament Protein Vimentin belongs to type III intermediate filament (IF) proteins selectively enriched within mesenchymal-derived cell populations across mammalian tissue systems....
Read More
ROR1 Reagents & Antibodies: Core Research Tools for Orphan RTK Tumor Targ...
Structural Features & Tumor-Specific Expression Profile of ROR1 Receptor Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) is a type I transmembrane glycoprotein belonging to the ROR receptor superfamily with distinct...
ROR1 Reagents & Antibodies: Core Research Tools for Orphan RTK Tumor Targ...
Structural Features & Tumor-Specific Expression Profile of ROR1 Receptor Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) is a type I transmembrane glycoprotein belonging to the ROR receptor superfamily with distinct...
Read More
TROP2 (TACSTD2): Target Biomarker and Matching Antibody Tools for Solid Tumor...
Structural Architecture and Oncogenic Signaling of TROP2 Transmembrane Glycoprotein TROP2, encoded by human TACSTD2 gene, is a 36–42 kDa type I transmembrane glycoprotein with layered modular structural domains that dictate...
TROP2 (TACSTD2): Target Biomarker and Matching Antibody Tools for Solid Tumor...
Structural Architecture and Oncogenic Signaling of TROP2 Transmembrane Glycoprotein TROP2, encoded by human TACSTD2 gene, is a 36–42 kDa type I transmembrane glycoprotein with layered modular structural domains that dictate...
Read More
Tumor-Associated Custom Antibodies: Versatile Research Reagents for Multi-Dim...
Core Unmet Demands for Custom Antibodies in Modern Oncology Basic Research Cancer progression arises from interconnected genomic mutations, epigenetic reprogramming, kinase pathway dysregulation and reshaped tumor immune microenvironments that demand...
Tumor-Associated Custom Antibodies: Versatile Research Reagents for Multi-Dim...
Core Unmet Demands for Custom Antibodies in Modern Oncology Basic Research Cancer progression arises from interconnected genomic mutations, epigenetic reprogramming, kinase pathway dysregulation and reshaped tumor immune microenvironments that demand...
Read More
Custom Antibody Development for Cancer Research: Specialized Reagents to Unra...
Unmet Reagent Demands Driving Custom Antibody Programs in Oncology Basic Research Tumor pathology arises from layered genomic mutations, dysregulated kinase signaling and reshaped immune microenvironment circuits that require highly specific...
Custom Antibody Development for Cancer Research: Specialized Reagents to Unra...
Unmet Reagent Demands Driving Custom Antibody Programs in Oncology Basic Research Tumor pathology arises from layered genomic mutations, dysregulated kinase signaling and reshaped immune microenvironment circuits that require highly specific...
Read More
FCM Multiplex Bead Assay: Revolutionary Technology for Simultaneous Multiplex...
Overview Accurate and high-throughput multiplex protein quantification is a core demand for researchers in life science and clinical testing. As a multiplex protein quantification technology built on flow cytometry, FCM...
FCM Multiplex Bead Assay: Revolutionary Technology for Simultaneous Multiplex...
Overview Accurate and high-throughput multiplex protein quantification is a core demand for researchers in life science and clinical testing. As a multiplex protein quantification technology built on flow cytometry, FCM...
Read More